4-Aminopyridine Toxicity: a Case Report and Review of the Literature
Journal of Medical Toxicology, 07/17/2012
King AM et al. – Adjunctive use of dopamine antagonists for extrapyramidal effects after sedation is a treatment possibility. As 4–aminopyridine recently received Federal Drug Administration approval for the treatment of ambulation in patients with MS, physicians should be keenly aware of its presentation, mechanism of action, and management in overdose.